Thomas Layloff

TL;DR: The report presents the assessment of the major agreements and issues discussed at the conference onAnalytical Methods Validation to provide guiding principles for validation of analytical methods used in bioavailability, bioequivalence, and pharmacokinetics studies in humans and animals.

TL;DR: The report presents the assessment of the major agreements and issues discussed at the conference on analytical methods validation and provides guiding principles for validation of analytical methods used in bioavailability, bioequivalence, and pharmacokinetics studies in humans and animals.

TL;DR: This is a summary report of the conference on Analytical Methods Validation: Bioavailability, Bioequivalence and Pharmacokinetic Studies, held from December 3 to 5, 1990 in the Washington, DC area and was sponsored by the American Association of Pharmaceutical Scientists.

TL;DR: Analytical Methods Validation: Bioavailability, Bioequivalence and Pharmacokinetic Studies as mentioned in this paper was the first conference on validation of analytical methods for bioavailability, bioequivalent, and pharmacokinetic studies.

TL;DR: The method has been successfully demonstrated and used in Swaziland, by high school teachers in the United States, and by personnel from the Ministry of Health in Saudi Arabia, proving that the screening process can be conducted by using reference tablets and without weighing either the sample or the reference.